Jisc strikes unlimited open access publishing deal with Rockefeller University Press

Jisc strikes unlimited open access publishing deal with Rockefeller University Press

Education and research not-for-profit Jisc has sealed a deal with Rockefeller University Press (RUP). The agreement provides participating UK higher education institutions unlimited Immediate Open Access publishing in RUP journals.

RUP, a department of the Rockefeller University in New York City, has agreed to a two year pilot deal with Jisc negotiating open access agreements with publishers on behalf of all UK universities covering RUP’s three hybrid journals, Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM) and Journal of General Physiology (JGP).

Participating UK institutions will receive unlimited access to content immediately after publication and articles by authors affiliated with these institutions will be published with immediate open access under a CC-BY license and directly deposited in PubMed Central (PMC) with no limit as all publishing fees are included in a fixed price.

RUP executive director Susan King said: “RUP has long championed sustainable public access and is delighted to partner with Jisc to reduce the administrative burden on UK faculty and students who choose to publish their research in JCB, JEM and JGP. We are pleased to be the first university publisher to sign the pilot agreement in the US, and we look forward to evaluating what we anticipate being a positive impact on the authors and readers at participating UK institutions.”

According to Jisc licensing manager Kathryn Spiller “many US society journals are important for UK authors” and the company is keen to have deals in place allowing them to continue publishing in these titles after January 2021.

Jisc said it is working with smaller publishers to make open access financially sustainable. The company previously secured agreements with Microbiology Society, IoP Publishing and five other learned societies.

The pilot will run from March 2020 until February 2022.